Latest
Amgen wins lawsuit against Regeneron, Sanofi for violating patents
A federal jury decided in favor of Amgen on March 16 in a lawsuit filed against Regeneron Pharmaceuticals and Sanofi for violating patents on a cholesterol reducing drug. In October 2014, Thousand Oaks-based Amgen sued Paris-based Sanofi and Tarrytown, N.Y.-based Regeneron for violating patents on its cholesterol reducing drug Repatha. Sanofi and Regeneron co-developed Praluent Read More →
